The group's principal activities are to offer products and services to patients, providers, payers and pharmaceutical manufacturers in the fertility industry in 23 major markets. The group has twenty three fertility centers in major markets across the United States. Five of the fertility centers are designated as 'reproductive science centers(r)' that have access to the group's fertilitydirect program. The group is also involved in the additional activities of: (i) administrative services, including accounting and finance, human resource functions and purchasing of supplies and equipment; (ii) access to capital and servicing and financing of patient accounts receivable; (iii) marketing and sales; (iv) integrated information.
